Skip to content

Allphase Pharma Consulting, LLC

A Professional Service Provider for the Pharma Industry

Allphase Pharma Consulting, LLC
Menu
Secondary Menu

Primary menu

  • CONTACT
  • BLOGS
    • The Viewpoint
    • The News
    • Recent Literature
    • Did you know…?
    • QIDP Antibiotics
  • LEGAL
  • WELCOME

Secondary menu

  • The News
  • The Viewpoint
  • Did you know…?
  • Recent Literature
  • QIDP Antibiotics

Tag Archives: OECD

Overcoming Antimicrobial Resistance – A European Report Recommends Deja-Vu Action

Posted on March 18, 2016 by Harald — No Comments ↓

Sometimes one comes across a particularly well-written policy document which summarizes the status quo of antimicrobial resistance by connecting and synthesizing data from all kinds of sources into a coherent framework. The 2015 OECD Report on Antimicrobial Resistance in G7 Continue reading Overcoming Antimicrobial Resistance – A European Report Recommends Deja-Vu Action→

Share this:

  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to print (Opens in new window) Print
  • Click to email a link to a friend (Opens in new window) Email

Like this:

Like Loading...
Posted in Did you know...?, Recent Literature, The News, The Viewpoint | Tagged Allphase Pharma Consulting, AMA, antibiotic blog, antibiotic consumption, antibiotic resistance, antisepsis, Harald Reinhart, hygiene, IDSA, Ignaz Semmelweis, MRSA, OECD, Penicillin-resistant pneumococcus, PRSP | Leave a reply

Primary Sidebar Widget Area

Posts and Blogs

  • REGULATORY INTERACTIONS  – 1
  • PK/PD of BIOLOGICALS
  • NANOBODIES FOR AUTOIMMUNE DISEASES
  • About A Prepared Mind – In R&D
  • The 10 x ’20 Initiative – A Retrospective
  • BAFF / APRIL Inhibitors Homing in on IgAN
  • THE UTILITY OF FUTILITY
  • Sulopenem uUTI – Does It Suffice?
  • PUBLICATION OVERACHIEVERS
  • BLUJEPA / Gepotidacin APPROVED FOR UNCOMPLICATED UTI – 1

Subscribe to AllphasePharma Blogs via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Tags

ABSSSI Achaogen Allphase Pharma Consulting aminoglycoside antibiotic blog Avelox Bayer Ceftazidime/avibactam cIAI ciprofloxacin colistin Cubicin Cubist cUTI dalbavancin Dalvance daptomycin delafloxacin eravacycline FDA fosfomycin GSK Harald Reinhart levofloxacin Merck meropenem moxifloxacin MRSA Novartis omadacycline Orbactiv oritavancin P. aeruginosa Pfizer PK/PD plazomicin QIDP solithromycin tedizolid tetracycline Tetraphase tigecycline Tygacil vancomycin VAP

Footer menu

  • CONTACT
  • BLOGS
  • LEGAL
  • WELCOME
  • Email
Copyright © 2025 Allphase Pharma Consulting, LLC. All Rights Reserved.
Theme: Catch Box by Catch Themes
Scroll Up
%d